Photocure ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
PhotoCure ASA Appoints Erik Dahl as Chief Financial Officer
PhotoCure ASA announced that it has appointed Erik Dahl to the Company's Management Team as Chief Financial Officer, effective as of August 15, 2012.
Latest Developments for Photocure ASA
- PhotoCure ASA Announces Positive Final Results of Phase 2B Cevira Study
- PhotoCure ASA Presents New Meta-Analysis Confirming Clinical Benefit of Hexvix-Guided Blue Light Cystoscopy
- PhotoCure ASA to Present Positive Data from Phase 2b Trial with Cevira
- PhotoCure ASA Announces Positive Results of Cevira Study
Latest Key Developments in Pharmaceuticals
- Sorrento Therapeutics Inc completes acquisition of Concortis Biosystems
- Jazz Pharmaceuticals PLC's Subsidiary and Gentium SpA announce agreement for Jazz Pharmaceuticals to acquire Gentium for $57.00 per share
- Amgen Inc's cholesterol drug succeeds in late-stage trial - Reuters
- Zoetis Inc declares first quarter 2014 dividend
- Share this
- Digg this